skip to main content
Refinado por: Nome da Publicação: Antimicrobial Agents And Chemotherapy remover assunto: Kidney Failure, Chronic remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
Material Type:
Artigo
Adicionar ao Meu Espaço

Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients

Gauthier, Timothy P ; Wolowich, William R ; Reddy, Arathi ; Cano, Ennie ; Abbo, Lilian ; Smith, Laura B

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2392-2396 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

2
Nephrotoxicity comparison of two commercially available generic vancomycin products
Material Type:
Artigo
Adicionar ao Meu Espaço

Nephrotoxicity comparison of two commercially available generic vancomycin products

Sutton, Jesse D ; Mynatt, Ryan P ; Kaye, Keith S ; Murray, Kyle P ; Rybak, Michael J ; Pogue, Jason M

Antimicrobial agents and chemotherapy, 2015-09, Vol.59 (9), p.5470-5474 [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

3
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
Material Type:
Artigo
Adicionar ao Meu Espaço

Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

Rigatto, Maria Helena ; Oliveira, Maura S ; Perdigão-Neto, Lauro V ; Levin, Anna S ; Carrilho, Claudia M ; Tanita, Marcos Toshiyuki ; Tuon, Felipe F ; Cardoso, Douglas E ; Lopes, Natane T ; Falci, Diego R ; Zavascki, Alexandre P

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2443-2449 [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

4
Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment
Material Type:
Artigo
Adicionar ao Meu Espaço

Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment

Preston, Richard A ; Mamikonyan, Grigor ; DeGraff, Stephane ; Chiou, James ; Kemper, Christopher J ; Xu, Allan ; Mastim, Mushtaque ; Yeole, Ravindra ; Chavan, Rajesh ; Patel, Anasuya ; Friedland, H David ; Bhatia, Ashima

Antimicrobial agents and chemotherapy, 2019-01, Vol.63 (1) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

5
Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-Tazobactam
Material Type:
Artigo
Adicionar ao Meu Espaço

Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-Tazobactam

WOOLEY, Myra ; MILLER, Benjamin ; KRISHNA, Gopal ; HERSHBERGER, Ellie ; CHANDORKAR, Gurudatt

Antimicrobial agents and chemotherapy, 2014-04, Vol.58 (4), p.2249-2255 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

6
Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment
Material Type:
Artigo
Adicionar ao Meu Espaço

Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment

Flanagan, S ; Minassian, S L ; Morris, D ; Ponnuraj, R ; Marbury, T C ; Alcorn, H W ; Fang, E ; Prokocimer, P

Antimicrobial agents and chemotherapy, 2014-11, Vol.58 (11), p.6471-6476 [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

7
Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease
Material Type:
Artigo
Adicionar ao Meu Espaço

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

Moltó, José ; Graterol, Fredzzia ; Miranda, Cristina ; Khoo, Saye ; Bancu, Ioana ; Amara, Alieu ; Bonjoch, Anna ; Clotet, Bonaventura

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2564-2566 [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

8
Reduction in Tedizolid Plasma Exposure among End-Stage Renal Disease Patients Undergoing Dialysis Is Explained by Variations in Ideal Body Weight
Material Type:
Artigo
Adicionar ao Meu Espaço

Reduction in Tedizolid Plasma Exposure among End-Stage Renal Disease Patients Undergoing Dialysis Is Explained by Variations in Ideal Body Weight

Flanagan, Shawn ; Prokocimer, Philippe

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.3246-3247 [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

9
Pharmacokinetics of Telbivudine in Subjects with Various Degrees of Renal Impairment
Material Type:
Artigo
Adicionar ao Meu Espaço

Pharmacokinetics of Telbivudine in Subjects with Various Degrees of Renal Impairment

ZHOU, Xiao-Jian ; SWAN, Suzanne ; SMITH, William B ; MARBURY, Thomas C ; DUBUC-PATRICK, Gloria ; CHAO, George C ; BROWN, Nathaniel A

Antimicrobial Agents and Chemotherapy, 2007-12, Vol.51 (12), p.4231-4235 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

10
Single-Dose Pharmacokinetics, Safety, and Tolerability of Albinterferon Alfa-2b in Subjects with End-Stage Renal Disease on Hemodialysis Compared to Those in Matched Healthy Volunteers
Material Type:
Artigo
Adicionar ao Meu Espaço

Single-Dose Pharmacokinetics, Safety, and Tolerability of Albinterferon Alfa-2b in Subjects with End-Stage Renal Disease on Hemodialysis Compared to Those in Matched Healthy Volunteers

Serra, Denise B ; Sun, Haiying ; Karwowska, Sylwia ; Praestgaard, Jens ; Halabi, Atef ; Stein, Daniel S

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.473-477 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.